期刊
FRONTIERS IN MOLECULAR NEUROSCIENCE
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnmol.2018.00051
关键词
Alzheimer's disease; basal forebrain; cholinergic neuron; amyloid-beta; brain-derived neurotrophic factor; APP/PS1 transgenic mouse
资金
- National Health and Medical Research Council of Australia [1049236]
- Australian Postgraduate Award
- Alzheimer's Australia Dementia Research Foundation Top-Up Scholarship
- Australian Research Council Linkage Infrastructure, Equipment and Facilities Grant [LE100100074]
- Alzheimers Research UK [ARUK-TVPG2017-1] Funding Source: researchfish
Degeneration of basal forebrain cholinergic neurons (BFCNs) precedes hippocampal degeneration and pathological amyloid-beta (A beta) accumulation, and underpins the development of cognitive dysfunction in sporadic Alzheimer's disease(AD). We hypothesized that degeneration of BFCNs causes a decrease in neurotrophin levels in innervated brain areas, which in turn promotes the development of A beta pathology and cognitive impairment. Here we show that lesion of septo-hippocampal BFCNs in a pre-symptomatic transgenic amyloid AD mouse model (APP/PS1 mice) increases soluble A beta levels in the hippocampus, and induces cognitive deficits in a spatial memory task that are not seen in either unlesioned APP/PS1 or non-transgenic littermate control mice. Furthermore, the BFCN lesion results in decreased levels of brain-derived neurotrophic factor (BDNF). However, viral knockdown of neuronal BDNF in the hippocampus of APP/PS1 mice (in the absence of BFCN loss) neither increased the level of A beta nor caused cognitive deficits. These results suggest that the cognitive decline and A beta pathology induced by BFCN loss occur independent of dysfunctional neuronal BDNF signaling, and may therefore be directly underpinned by reduced cholinergic neurotransmission.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据